Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OXY vs GSK✓SelectedUSD · GSKOXY vs GSK performance historyLatest closeAs of-4.88%11/18
Stock and ETF performance explorer

OXY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,188.5%
GSK return
+1,674.3%
Excess return
-485.7%
Maximum drawdown
-88.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.9%-1.3%-3.5%-4.5%
7D-6.1%-3.1%-3.0%-5.2%
30D-14.3%-0.9%-13.4%-14.2%
3M-9.7%-4.2%-5.5%-9.0%
6M-9.1%-1.6%-7.5%-9.5%
YTD+32.6%+2.6%+30.0%+29.4%
1Y+29.0%+6.2%+22.7%+24.5%
3Y-6.8%+55.0%-61.8%-21.4%
5Y+88.6%+42.8%+45.8%+60.6%
10Y+3.5%+102.1%-98.6%-20.4%
All+1,188.5%+1,674.3%-485.7%+563.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling